Isoform switching of steroid receptor co-activator-1 attenuates glucocorticoid-induced anxiogenic amygdala CRH

I Zalachoras1,2, S L Verhoeve1,2, L J Toonen3

  • 1Division of Endocrinology, Department of Medicine, Leiden University Medical Center, Leiden, The Netherlands.

Molecular Psychiatry
|March 16, 2016
PubMed

Insights

Altering steroid receptor coactivator-1 (SRC-1) splicing in mice reduced stress hormone effects on fear behavior. This manipulation selectively targets glucocorticoid receptor (GR) signaling, offering potential for stress-related psychopathology treatments.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Endocrinology

Background:

  • Maladaptive glucocorticoid effects are implicated in stress-related psychopathology.
  • The glucocorticoid receptor (GR) mediates these effects through various signaling pathways.
  • Corticotropin releasing hormone (CRH) is a key mediator in stress responses.

Purpose of the Study:

  • To test if manipulating coregulators can mitigate maladaptive GR effects on fear behavior.
  • To investigate the role of steroid receptor coactivator-1 (SRC-1) splice variants in GR signaling.
  • To determine if altering SRC-1 splicing affects CRH gene expression and methylation.

Main Methods:

  • Antisense-mediated exon-skipping was used to alter SRC-1 splice variants in the mouse central amygdala.
  • CRH mRNA expression and promoter methylation were analyzed.
  • Glucocorticoid responsiveness of the Fkbp5 gene was assessed.
  • Glucocorticoid-dependent exploratory behavior and fear memory consolidation were evaluated.

Main Results:

  • Shifting SRC-1 splicing towards the repressive SRC-1a isoform reduced glucocorticoid-induced CRH mRNA expression.
  • Increased methylation of the Crh promoter was observed.
  • The Fkbp5 gene remained responsive to glucocorticoids, showing gene-specific effects.
  • Altered SRC-1 splicing affected exploratory behavior and attenuated fear memory consolidation.

Conclusions:

  • Manipulation of GR signaling pathways, specifically targeting the CRH gene, can selectively reduce maladaptive glucocorticoid effects.
  • Altering the ratio of SRC-1 splice variants offers a potential strategy to modulate stress responses.
  • These findings highlight the role of coregulators in fine-tuning GR actions and their implications for psychopathology.

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.6K
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.3K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
613
Hypothalamic-Pituitary Axis01:37

Hypothalamic-Pituitary Axis

The response to stress—be it physical or psychological, acute or chronic—involves activation of the Hypothalamic-Pituitary-Adrenal (HPA) axis. The HPA axis is part of the neuroendocrine system because it involves both neuronal and hormonal communication. Its function is to regulate homeostatic systems—metabolic, cardiovascular, and immune—providing the necessary means to respond to a stressor.
69.7K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.2K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.5K